London, UK and Paris, France 03 September 2020 — Sanofi and GSK announce today the start of the Phase 1/2
Continue reading »Home ยป
Drug candidate may recover vocal abilities lost to ADNP syndrome
Activity-dependent neuroprotective protein syndrome (ADNP syndrome) is a rare genetic condition that causes developmental delays, intellectual disability and autism spectrum
Continue reading »Candidate drug may be effective against broader class of brain cancers
A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor (EGFR), a cell surface
Continue reading »Novel HIV vaccine candidate is safe and induces immune response in healthy adults and monkeys
New research published in The Lancet shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust
Continue reading »